What is hepatitis B and how can university students prevent and manage it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis B: Essential Information for University Students

What is Hepatitis B?

Hepatitis B is a viral infection caused by the hepatitis B virus (HBV) that attacks the liver and can lead to both acute and chronic disease, including cirrhosis and liver cancer. 1

  • HBV is a small DNA virus that infects more than 300 million people worldwide and represents a major public health problem causing significant morbidity and mortality 1, 2
  • The virus contains partially double-stranded DNA surrounded by core antigen (HBcAg) and an outer envelope containing surface antigen (HBsAg) 3
  • HBV replicates through an RNA intermediate and can integrate into the host genome, giving it a unique ability to persist in infected cells 1

How is Hepatitis B Transmitted?

HBV spreads through contact with infected blood, semen, and other body fluids. 2

  • Transmission occurs through sexual contact, sharing needles, or exposure to infected blood 4
  • Healthcare workers and students face higher risk due to potential occupational exposure to blood and body fluids 5
  • The virus does NOT spread through casual contact like sharing food or hugging 6

Clinical Course and Outcomes

The outcome of HBV infection depends heavily on age at infection and immune status. 3

Acute vs. Chronic Infection:

  • 90% of newborns who become infected develop chronic hepatitis 3
  • 29-40% of children infected develop chronic disease 3
  • Only 5-10% of adults infected progress to chronic infection 3, 2

Long-term Consequences:

  • Up to 40% of men and 15% of women with perinatally acquired HBV will die of liver cirrhosis or hepatocellular carcinoma 2
  • Five-year survival rates vary: 97% for chronic persistent hepatitis, 86% for chronic active hepatitis, and 55% for chronic active hepatitis with cirrhosis 3

Prevention: The Hepatitis B Vaccine

The hepatitis B vaccine is the single most effective tool for preventing HBV infection and is the first anticancer vaccine ever developed. 7

Vaccination Recommendations for Students:

  • All healthcare providers and students should receive the complete 3-dose hepatitis B vaccine series 8
  • Vaccination should be followed by testing for hepatitis B surface antibody (anti-HBs) 1-2 months after completing the series to confirm immunity 8
  • Protective antibody level is defined as >10 mIU/ml 8
  • If initial series doesn't produce immunity, revaccination with 3 additional doses (total of 6 doses) should be given 8

Vaccine Effectiveness:

  • The vaccine is safe, effective, and affordable 7
  • Global coverage reached 85% in 2019 compared to only 30% in 2000 7
  • Implementation of vaccination programs has substantially decreased HBV carrier rates and related morbidity and mortality 7

Current Trends and New Options

Testing Recommendations:

  • Students at increased risk should undergo prevaccination testing, including those born to mothers from endemic countries (Asia, Africa, Middle East) and sexually active men who have sex with men 8
  • Testing involves checking for HBsAg (surface antigen), anti-HBc (core antibody), and anti-HBs (surface antibody) 8

Treatment Options for Chronic Infection:

Two main antiviral medications are available for chronic HBV:

  1. Tenofovir disoproxil fumarate 6:

    • Taken once daily on an empty stomach
    • Can cause kidney problems, so monitoring is required
    • Effective at suppressing viral replication
  2. Entecavir 9:

    • Taken once daily on an empty stomach (at least 2 hours after and before meals)
    • Generally well-tolerated with headache, tiredness, and dizziness as common side effects
    • Long-term treatment can reverse cirrhosis and reduce hepatocellular carcinoma risk 2

Important Treatment Considerations:

  • Never stop antiviral medication without consulting a healthcare provider, as this can cause severe liver problems 6, 9
  • Patients must continue medication even when feeling well to prevent viral rebound 6, 9
  • Regular monitoring of kidney function and liver enzymes is essential during treatment 6

Protection Practices for University Students

All students should adopt standard precautions to prevent HBV transmission: 4

Essential Safety Measures:

  • Never share needles, syringes, or any injection equipment 4, 6, 9
  • Avoid sharing personal items that may contact blood (toothbrushes, razors, nail clippers) 6, 9
  • Always practice safe sex using latex or polyurethane condoms 6
  • Wear gloves when touching blood or body fluids 4
  • Never recap needles using both hands or any technique directing the needle toward your body 4

For Healthcare and Public Health Students:

  • Chronic HBV infection should not preclude studying medicine, dentistry, or allied health professions 8
  • Students performing non-invasive or minimally invasive procedures face no restrictions on their activities 8
  • Standard precautions must be followed rigorously in all healthcare settings 8
  • No transmission from a dental or medical student has ever been reported in the United States 8

Knowledge Gaps Among Students

Recent studies reveal concerning gaps in HBV knowledge and prevention practices among university students: 5

  • In a study of public health students in Ghana, only 73.9% had moderate knowledge about HBV 5
  • 50.4% had never been tested for HBV infection 5
  • Only 30.5% completed the full vaccination series 5
  • Students with better knowledge were significantly more likely to get tested (nearly 5 times more likely) 5
  • Female students and regular (non-mature) students were more likely to complete vaccination 5

Critical Pitfalls to Avoid

  • Do not assume you're protected without confirming antibody response after vaccination 8
  • Never share multi-dose medication vials or IV bags between patients in clinical settings 4
  • Inadequate hand hygiene between patients increases transmission risk 4
  • Do not delay getting tested if you're from an endemic region or have risk factors 8
  • Never discontinue antiviral therapy without medical supervision, as severe liver flares can occur 6, 9

References

Research

Hepatitis B: the virus and disease.

Hepatology (Baltimore, Md.), 2009

Research

Hepatitis B virus infection.

Lancet (London, England), 2014

Guideline

Safe Injection Practices to Prevent Transmission of Bloodborne Pathogens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hepatitis B Vaccines.

The Journal of infectious diseases, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.